| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/20/2006 | EP1292621B1 Compositions for treating autoimmune disease |
| 09/20/2006 | EP1280897B1 Regulation of nf-at interacting protein nip 45 variant |
| 09/20/2006 | EP1246841B1 Transcription factors containing two potential dna binding motifs |
| 09/20/2006 | EP1144007B1 Molecularly imprinted microspheres prepared using precipitation polymerisation |
| 09/20/2006 | EP1079875B1 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |
| 09/20/2006 | EP1051191B1 CD154 BLOCKADE THERAPY FOR PANCREATIC ISLET TISSUE TRANSPLANTATION in primates |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0914153B1 Multivalent dtp-polio vaccines |
| 09/20/2006 | CN1835977A CD20-binding polypeptide compositions |
| 09/20/2006 | CN1835976A Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof |
| 09/20/2006 | CN1835975A Modified human IGF-1R antibodies |
| 09/20/2006 | CN1835974A Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 09/20/2006 | CN1835973A Compositions and methods for treatment of cryptococcosis |
| 09/20/2006 | CN1835972A Combination therapy for B cell disorders |
| 09/20/2006 | CN1835769A KIM-1 antagonists and use to modulate immune system |
| 09/20/2006 | CN1835768A Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies |
| 09/20/2006 | CN1835767A Canine vaccines against bordetella bronchiseptica |
| 09/20/2006 | CN1835679A Process for producing human-origin immunocompetent cell |
| 09/20/2006 | CN1833724A Cancer treatment through suction effect T-cell and loss regulating T-cell |
| 09/20/2006 | CN1833723A Chain coccus recombination subunit vaccine and prepn. thereof |
| 09/20/2006 | CN1276076C No mark gene deletion deoxidated mutant strain of wild Manhu bacteria and its use |
| 09/20/2006 | CN1275650C Coupled compound of 5-methyl-morpholine-3-amino-2-oxazolidinone and preparation method thereof |
| 09/20/2006 | CN1275649C Bivalence polypeptide vaccine for resisting A type and O type foot-and-mouth disease virus and its preparation |
| 09/20/2006 | CN1275648C Vaccin composition, preparation method and use thereof |
| 09/19/2006 | US7109308 Inhibiting tumor growth, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis; diagnostic methods for detecting mutations in the VEGF2 coding sequence and alterations in the concentration of VEGF2 protein |
| 09/19/2006 | US7109306 Antibody or fragment that specifically binds to a protein, decrease in the level of mim-1 protein is observed; inhibiting abnormal cell proliferation or differentiation |
| 09/19/2006 | US7109304 Humanized anti-CD19 antibodies |
| 09/19/2006 | US7109301 Tenascin-C isoform as marker for neoplasias |
| 09/19/2006 | US7109183 Phosphohalohydrins, process for the production thereof and use thereof |
| 09/19/2006 | US7109182 Synthetic oligomannosides, preparation and uses thereof |
| 09/19/2006 | US7109031 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/19/2006 | US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 09/19/2006 | US7109025 Viral vectors and viral vaccines based on recombinant porcine adenoviruses |
| 09/19/2006 | US7109011 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
| 09/19/2006 | US7109003 Methods for expressing and recovering human monoclonal antibodies to CTLA-4 |
| 09/19/2006 | US7108995 Small peptides having apoptotic activities and their applications |
| 09/19/2006 | US7108967 Using immunoglobulin which binds specifically to hepatitis envelope antigens E1 and E2 to detect viral infection |
| 09/19/2006 | US7108863 Liposome composition for improved intracellular delivery of a therapeutic agent |
| 09/19/2006 | US7108858 Immunological protein |
| 09/19/2006 | US7108857 Therapy for injured muscles |
| 09/19/2006 | US7108856 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/19/2006 | US7108855 Characterized in that upon lysing the transformed host cells to isolate the recombinantly expressed protein a disulphide bond cleavage or reduction step is carried out with a disulphide bond cleavage agent |
| 09/19/2006 | US7108854 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 09/19/2006 | US7108853 Surface protein of Leptospira |
| 09/19/2006 | US7108852 Methods of treating inflammation using antibodies to M-CSF |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/14/2006 | WO2006096861A2 METHODS FOR IDENTIFYING TUMORS RESPONSIVE TO TREATMENT WITH HER DIMERIZATION INHIBITORS (HDIs) |
| 09/14/2006 | WO2006096491A2 Anti-ctla-4 antibody compositions |
| 09/14/2006 | WO2006096488A2 Composition comprising human igg2 antibody and chelating agent |
| 09/14/2006 | WO2006096451A2 Methionine sulfoxide antibodies |
| 09/14/2006 | WO2006096011A1 PHARMACEUTICAL COMPOSITION FOR TREATING AVELLINO CORNEA DYSTROPHY COMPRISING AN ANTIBODY AGAINST TGF-β |
| 09/14/2006 | WO2006095446A1 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 09/14/2006 | WO2006095431A1 Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine |
| 09/14/2006 | WO2006095330A2 Methods and immunogenic cell preparations for treating antigen-associated diseases |
| 09/14/2006 | WO2006095180A2 Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars |
| 09/14/2006 | WO2006095176A2 Vaccine formulation |
| 09/14/2006 | WO2006094974A2 Chemically defined stabiliser composition |
| 09/14/2006 | WO2006094828A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 09/14/2006 | WO2006094756A2 Varicella zoster virus vaccine |
| 09/14/2006 | WO2006094704A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/14/2006 | WO2006094402A1 Novel hemoglobin scavenger receptor, cd163, and method of increasing cd163 expression on human stem cells and stimulation of erythroid progenitors |
| 09/14/2006 | WO2006094385A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 09/14/2006 | WO2006094384A1 Use of interleukin 17e for the treatment of cancer |
| 09/14/2006 | WO2006080842A3 Oral vaccines for fish |
| 09/14/2006 | WO2006078268A3 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 09/14/2006 | WO2006072787A8 Compositions for immunizing against mycobacterium |
| 09/14/2006 | WO2006072304A3 Tumor antigens for use in diagnosis and therapy |
| 09/14/2006 | WO2006069073A3 Use of angiopoietins in anti-tumor therapy |
| 09/14/2006 | WO2006065888A3 Targeted iron chelator delivery system |
| 09/14/2006 | WO2006052285A3 Polymeric nanoparticles and nanogels for extraction and release of compounds |
| 09/14/2006 | WO2006046017A3 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 09/14/2006 | WO2006044499A3 Consortium of nitrifying bacteria |
| 09/14/2006 | WO2006034334A3 Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| 09/14/2006 | WO2005117964A3 Cynomolgus prostate specific antigen |
| 09/14/2006 | WO2005117936A3 Method for enhancing or inhibiting insulin-like growth factor-i |
| 09/14/2006 | WO2005115113A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/14/2006 | WO2005097186A3 Bioactive stents for type ii diabetics and methods for use thereof |
| 09/14/2006 | WO2005086875A3 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/14/2006 | WO2005074607A3 Method of treating hemolytic disease |
| 09/14/2006 | WO2005065418A3 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 09/14/2006 | WO2005011376A3 Altered antibodies having improved antigen-binding affinity |
| 09/14/2006 | WO2004098489A3 Compositions and methods for modulation of specific epitopes of hsp60 |
| 09/14/2006 | WO2004075836A3 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | WO2004037192A3 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/14/2006 | US20060205925 Inhibits hemolysis by interacting with the plasma proteins clusterin; histidine rich glycoprotein (HRG); Streptococcal Inhibitor of Complement-mediated lysis |
| 09/14/2006 | US20060205924 Spliced variants of lgr6 |
| 09/14/2006 | US20060205809 Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 09/14/2006 | US20060205764 Inhibition of platelet aggregation |
| 09/14/2006 | US20060205668 For therapy of spinal cord injury or stroke, by overcoming the inhibitory effects of myelin on axonal regeneration |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205072 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 09/14/2006 | US20060205069 Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells |
| 09/14/2006 | US20060205033 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060204986 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |